Emcure Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE168P01015
  • NSEID: EMCURE
  • BSEID: 544210
INR
1,907.55
-16.2 (-0.84%)
BSENSE

Jul 28, 02:01 PM

BSE+NSE Vol: 2.66 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 10039308,
    "name": "Emcure Pharma",
    "stock_name": "Emcure Pharma",
    "full_name": "Emcure Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/emcure-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,907.55",
    "chg": -16.2,
    "chgp": "-0.84%",
    "dir": -1,
    "prev_price": "1,923.75",
    "mcapval": "36,182.44 Cr",
    "mcap": "Small Cap",
    "scripcode": 544210,
    "symbol": "EMCURE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE168P01015",
    "curr_date": "Jul 28, 02:01 PM",
    "curr_time": "14:02 PM",
    "last_traded_at": "Jul 28, 02:01 PM IST",
    "bse_nse_vol": "2.66 lacs",
    "exc_status": "Active",
    "traded_date": "Jul 28, 2026",
    "traded_date_str": "2026 07 28",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/emcure-pharma-10039308-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Broad-Based Technical Strength Lifts Emcure Pharmaceuticals Ltd to 52-Week High of Rs 1957.8",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-hits-new-52-week-high-at-rs19578-4124156",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/EmcurePharmaceu_priceRelatedfactors_4124156.png",
        "date": "2026-07-28 10:20:11",
        "description": "With a decisive break above Rs 1957.8 on 28 Jul 2026, Emcure Pharmaceuticals Ltd has reached a fresh 52-week and all-time high, propelled by a confluence of bullish technical indicators and sustained price momentum."
      },
      {
        "title": "Emcure Pharmaceuticals Ltd Hits All-Time High of Rs 1,946.90 as Momentum Builds Across Timeframes",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-hits-all-time-high-marking-a-significant-milestone-4124117",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/EmcurePharmaceu_priceRelatedfactors_4124117.png",
        "date": "2026-07-28 10:07:55",
        "description": ""
      },
      {
        "title": "Emcure Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/emcure-pharmaceuticals-ltd-is-rated-hold-4120130",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/EmcurePharmaceu_mojoScore_4120130.png",
        "date": "2026-07-25 10:10:41",
        "description": "Emcure Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 July 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Emcure Pharmaceuticals Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-technical-momentum-shifts-signal-bullish-outlook-4103194",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/EmcurePharmaceu_technicaldot_4103194.png",
        "date": "2026-07-15 08:05:30",
        "description": "Emcure Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underscored by positive signals from key technical indicators such as the MACD, moving averages, and Bollinger Bands, alongside a robust year-to-date return of 32.64%, significantly outperforming the Sensex’s negative 9.58% over the same period."
      },
      {
        "title": "Emcure Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/emcure-pharmaceuticals-ltd-is-rated-hold-4100787",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/EmcurePharmaceu_mojoScore_4100787.png",
        "date": "2026-07-14 10:10:36",
        "description": "Emcure Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 July 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Emcure Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-market-signals-4100109",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/EmcurePharmaceu_technicaldot_4100109.png",
        "date": "2026-07-14 08:06:52",
        "description": "Emcure Pharmaceuticals Ltd has experienced a subtle shift in its technical momentum, transitioning from a bullish to a mildly bullish stance as of mid-July 2026. Despite a slight dip in the daily price, the stock’s technical indicators present a nuanced picture, reflecting both resilience and caution within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Emcure Pharmaceuticals Ltd Technical Momentum Shifts to Bullish Amid Strong Year-to-Date Gains",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-technical-momentum-shifts-to-bullish-amid-strong-year-to-date-gains-4092946",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/EmcurePharmaceu_technicaldot_4092946.png",
        "date": "2026-07-08 08:06:32",
        "description": "Emcure Pharmaceuticals Ltd has recently exhibited a notable shift in its technical momentum, upgrading from a mildly bullish to a bullish stance. This change is underpinned by a confluence of positive signals across key technical indicators including MACD, Bollinger Bands, and moving averages, signalling renewed investor interest and potential upside in the small-cap pharmaceutical stock."
      },
      {
        "title": "Emcure Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4091562",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/EmcurePharmaceu_technicaldot_4091562.png",
        "date": "2026-07-07 08:08:26",
        "description": "Emcure Pharmaceuticals Ltd has experienced a subtle shift in its technical momentum, moving from a bullish to a mildly bullish stance as of early July 2026. Despite a slight dip in the daily price, key technical indicators such as MACD, RSI, and moving averages reveal a complex picture of the stock’s near-term trajectory within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Emcure Pharmaceuticals Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/emcure-pharmaceuticals-ltd-is-rated-hold-by-marketsmojo-4087387",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/EmcurePharmaceu_mojoScore_4087387.png",
        "date": "2026-07-03 10:11:16",
        "description": "Emcure Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 July 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market performance."
      }
    ],
    "total": 441,
    "sid": "10039308",
    "stock_news_url": "https://www.marketsmojo.com/news/emcure-pharmaceuticals-10039308"
  },
  "announcements": [
    {
      "caption": "Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Update On Completion Of Acquisition Of Shares Of Gennova Biopharmaceuticals Limited.",
      "datetime": "22-Jul-2026",
      "details": "Update on completion of acquisition of shares of Gennova Biopharmaceuticals Limited",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "21-Jul-2026",
      "details": "Intimation under Regulation 30 of the SEBI (LODR) Regulations 2015 - Completion of 2nd term of Independent Director",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "20-Jul-2026",
      "details": "Press Release titled Emcure to Expand the Use of Poviztra for MASH Indication Following CDSCO Approval.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "06 Aug 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Emcure Pharmaceuticals Ltd has declared <strong>30%</strong> dividend, ex-date: 14 Aug 25",
          "dt": "2025-08-14",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Update On Completion Of Acquisition Of Shares Of Gennova Biopharmaceuticals Limited.

22-Jul-2026 | Source : BSE

Update on completion of acquisition of shares of Gennova Biopharmaceuticals Limited

Announcement under Regulation 30 (LODR)-Change in Management

21-Jul-2026 | Source : BSE

Intimation under Regulation 30 of the SEBI (LODR) Regulations 2015 - Completion of 2nd term of Independent Director

Announcement under Regulation 30 (LODR)-Press Release / Media Release

20-Jul-2026 | Source : BSE

Press Release titled Emcure to Expand the Use of Poviztra for MASH Indication Following CDSCO Approval.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

06 Aug 2026

stock-summary
DIVIDEND

Emcure Pharmaceuticals Ltd has declared 30% dividend, ex-date: 14 Aug 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available